Dosage form, device and methods of treatment

Details for Australian Patent Application No. 2002332975 (hide)

International Classifications

Event Publications

13 February 2003 Complete Application Filed

Priority application(s): PR 8390 19.10.01 AU

3 July 2003 Application Open to Public Inspection

Published as AU-B-2002332975

3 February 2005 Application Accepted

Published as AU-B-2002332975

12 May 2005 Opposition Lodged

Ancare New Zealand Limited has lodged an opposition against Eli Lilly and Company.

21 July 2005 Opposition Lodged

Merial Ltd has lodged an opposition against Eli Lilly and Company.

17 April 2008 Opposition Withdrawn

The opposition by Ancare New Zealand Limited against Eli Lilly and Company has been withdrawn.

11 September 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 14 May 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

29 January 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 09 Jan 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

29 January 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 14 May 2008

4 June 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 09 Jan 2009 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.